GlassScriptPhysician profile
Ivana Gojo
NPI 1194765677
$24,865.69
in general payments reported to CMS, 2019-2025
9 companies · $7,952 in 2025
The $7,952 reported for 2025 was more than what 86% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $6,488 · 2021: $3,720 · 2022: $6,706 · 2025: $7,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,605 · Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,605.00 |
| Food and Beverage | $347.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $8,909.50 | 2020-2021 | |
| Taiho Oncology, INC. | $4,803.46 | 2025 | |
| Astrazeneca Uk Limited | $4,110.00 | 2022 | |
| Amgen INC. | $3,894.00 | 2021-2022 | |
| Geron Corporation | $3,026.83 | 2025 | Imetelstat |
| Astellas Pharma US INC | $121.90 | 2025 | Xospata |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivana Gojo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.